General ENT News
ENT
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General ENT
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
ENT
        Allergy
        Basic Science/Genetics
        Clinical Pharmacology
        ENT Infectious Disease
        Economics of Medicine
        Endocrine
        Head and Neck
        Larynx/Trachea/Airway
        Nose
        Oral Cavity
        Otology/Neurotology
        Pediatric Otolaryngology
        Plastic/Reconstructive
        Popular Press
        Radiology/Diagnostics
        Salivary Glands
        Sinus
        Trauma
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Radiation therapy for minor salivary gland carcinoma
Cianchetti M et al. - In a study to analyze the outcomes of pts treated for minor salivary gland carcinoma with radiotherapy (RT), either alone or combined with surgery, it was found that most pts with minor salivary gland carcinoma were cured with RT alone or combined with surgery. Treatment group, T stage, and overall stage significantly influenced the probability of cure. Pts treated with combined surgery and RT had a better prognosis, perhaps due in part to selection bias.

Methods
  • 140 pts were treated with curative intent for previously untreated minor salivary gland carcinomas (RT alone, 64 pts; combined RT and surgery, 76 pts).
  • Median follow-up for all pts was 5.5 yrs.

Results
  • 10-yr local control rate was 66%, and multivariate analysis revealed that treatment group and T stage significantly influenced this endpoint.
  • Pts treated with RT alone had a lower local control rate than pts treated with RT and surgery.
  • 10-yr local-regional control rate was 61%, and multivariate analysis revealed that treatment group, overall stage, and N stage significantly influenced this endpoint.
  • 10-yr distant metastasis-free survival rate was 67%, and multivariate analysis revealed that overall stage significantly influenced this endpoint.
  • 10-yr cause-specific survival rate was 56%, and multivariate analysis revealed that overall stage significantly influenced this endpoint.
  • 10-yr overall survival rate was 45%, and multivariate analysis revealed that overall stage, N stage, and nerve invasion significantly influenced this endpoint.
[more...]

Read a Different Specialty

General ENT Articles
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

General ENT Articles
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.